Beta Hexoseaminidase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Positive pre-IND/CTA feedback obtained from several key regulatory agencies for TSHA-102 in Rett syndrome, TSHA-101 in GM2 gangliosidosis and TSHA-118 in CLN1 disease, paving the way for multiple. | August 17, 2021

United statesOmary newmanBeta hexoseaminidaseSilicon valley bankRare disease company coalitionQueen universityUs national institutes of healthExchange commissionDevelopment rd expensesTaysha gene therapies incRegulatory affairs at astellas gene therapiesUt southwestern gene therapy programTaysha gene therapiesIntramural programNational instituteNeurological disorders